Literature DB >> 18715679

Synthesis, spectral studies and in vitro antibacterial activity of steroidal thiosemicarbazone and their palladium (Pd (II)) complexes.

Salman Ahmad Khan1, Mohamad Yusuf.   

Abstract

We investigated the antibacterial activity of some new steroidal thiosemicarbazone and their Pd(II) metal complexes. Metal complexes were prepared from the reaction of steroidal thiosemicarbazone with [Pd(DMSO)(2)Cl(2)]. Coordination via the thionic sulphur and the azomethine nitrogen atom of the thiosemicarbazone to the metal ion, the thiosemicarbazone derivatives were obtained by the thiosemicarbazide with steroidal ketones. All the compounds have been confirmed by spectral data. The antibacterial activity of these compounds was first tested in vitro by the disk diffusion assay against two gram-positive and two gram-negative bacteria, and then the minimum inhibitory concentration (MIC) was determined. The results showed that steroidal complexes are better inhibit growth as compared to steroidal thiosemicarbazones of both types of the bacteria (gram-positive and gram-negative); compound Ia is better antibacterial agent as compared to amoxicillin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18715679     DOI: 10.1016/j.ejmech.2008.06.008

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  8 in total

1.  Synthesis and antimicrobial studies of novel derivatives of 4-(4-formyl-3-phenyl-1H-pyrazol-1-yl)benzoic acid as potent anti-Acinetobacter baumannii agents.

Authors:  Devin Allison; Evan Delancey; Hunter Ramey; Conrad Williams; Zakeyah Ali Alsharif; Hessa Al-Khattabi; Allyn Ontko; David Gilmore; Mohammad A Alam
Journal:  Bioorg Med Chem Lett       Date:  2016-12-29       Impact factor: 2.823

2.  Di-n-but-yl[N'-(3-meth-oxy-2-oxidobenzyl-idene)-N-phenyl-carbamohydrazono-thio-ato]tin(IV): crystal structure, Hirshfeld surface analysis and computational study.

Authors:  Enis Nadia Md Yusof; Huey Chong Kwong; Thiruventhan Karunakaran; Thahira B S A Ravoof; Edward R T Tiekink
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2021-02-23

3.  Novel palladium (II) complexes with tetradentate thiosemicarbazones. Synthesis, characterization, in vitro cytotoxicity and xanthine oxidase inhibition.

Authors:  Dilşad Özerkan; Onur Ertik; Buşra Kaya; Serap Erdem Kuruca; Refiye Yanardag; Bahri Ülküseven
Journal:  Invest New Drugs       Date:  2019-03-14       Impact factor: 3.850

4.  Benzaldehyde thiosemicarbazone derived from limonene complexed with copper induced mitochondrial dysfunction in Leishmania amazonensis.

Authors:  Elizandra Aparecida Britta; Ana Paula Barbosa Silva; Tânia Ueda-Nakamura; Benedito Prado Dias-Filho; Cleuza Conceição Silva; Rosana Lázara Sernaglia; Celso Vataru Nakamura
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

5.  A Target-Based Whole Cell Screen Approach To Identify Potential Inhibitors of Mycobacterium tuberculosis Signal Peptidase.

Authors:  Shilah A Bonnett; Juliane Ollinger; Susantha Chandrasekera; Stephanie Florio; Theresa O'Malley; Megan Files; Jo-Ann Jee; James Ahn; Allen Casey; Yulia Ovechkina; David Roberts; Aaron Korkegian; Tanya Parish
Journal:  ACS Infect Dis       Date:  2016-09-19       Impact factor: 5.084

6.  Evaluation of free radical scavenging capacity of methoxy containing-hybrids of thiosemicarbazone-triazole and their influence on glucose transport.

Authors:  Ademola O Ayeleso; Jitcy S Joseph; Oluwafemi O Oguntibeju; Emmanuel Mukwevho
Journal:  BMC Pharmacol Toxicol       Date:  2018-12-06       Impact factor: 2.483

7.  Synthesis and Antiproliferative Activity of Steroidal Thiosemicarbazone Platinum (Pt(II)) Complexes.

Authors:  Yanmin Huang; Erbin Kong; Chunfang Gan; Zhiping Liu; Qifu Lin; Jianguo Cui
Journal:  Bioinorg Chem Appl       Date:  2015-10-08       Impact factor: 7.778

8.  A class of hydrazones are active against non-replicating Mycobacterium tuberculosis.

Authors:  Shilah A Bonnett; Devon Dennison; Megan Files; Anumita Bajpai; Tanya Parish
Journal:  PLoS One       Date:  2018-10-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.